A B S T R A C T To study the effect of insulin on leucine kinetics, three groups of conscious dogs were studied after an overnight fast (16-18 h). One, saline-infused group (n = 5), served as control. The other two groups were infused with somatostatin and constant replacement amount of glucagon; one group (n = 6) received no insulin replacement, to produce acute insulin de- 36% drop in plasma leucine (from control levels of 128±8 to 82±7 smol/liter, P < 0.005) within 4 h. This was accompanied by a 15% reduction in Ra and a 56% rise in clearance (P < 0.001, both). Net hepatic leucine production and net release of leucine and KIC across the hindlimb fell markedly. These studies indicate that physiologic changes in circulating insulin levels result in a differential dose-dependent effect on total body leucine metabolism in the intact animal. Acute insulin withdrawal exerts no effect on leucine rate of appearance, while at twice basal levels, insulin inhibited leucine rate of appearance and stimulated its rate of disappearance.
INTRODUCTION
The effects of insulin on protein turnover in the intact animal (1, 2) or man (3) (4) (5) (6) have been primarily obtained from nitrogen balance studies. In the absence of insulin, the untreated insulin-dependent diabetic (7) or depancreatectomized dog (2) has enhanced nitrogen excretion, which is reversed with insulin replacement. These studies, however, fail to distinguish between changes in the rates of protein synthesis and degradation. In vitro studies in rat skeletal or cardiac muscles have established that insulin stimulates protein synthesis by enhancing peptide chain initiation and inhibits protein breakdown by a yet unknown mechanism (8) . In the liver, insulin exerts an anticatabolic effect, primarily due to stabilization of liver lysosomes (9, 10) . It is not clear from these studies, however, whether it is the effect of insulin on protein synthesis or degradation that predominates in vivo.
The effect of insulin on branched-chain amino acid homeostasis in the intact animal or man is not very well delineated. In high amounts, insulin suppresses the plasma concentration of most of the amino acids, and particularly leucine, isoleucine, and valine (3) . On the other hand, in situations of relative or absolute insulin deficiency, as in obesity (7), starvation (4, 11) , and diabetes mellitus (7) the concentrations of the branched-chain amino acids are elevated. It is not clear however, whether the changes observed in the plasma concentrations of the branched-chain amino acids are due to changes in their rates of appearance into or disappearance from the plasma compartment. Leucine, being an essential amino acid, its only source after an overnight fast must be from protein, and therefore changes in its rate of turnover in plasma will reflect changes in protein turnover. The studies presented herein were undertaken to examine the effect of physiologic changes in insulin levels on total leucine flux and on leucine balance across the hindlimb, the splanchnic and hepatic beds. To define the effects of acute insulin deficiency, independent of changes in glucagon secretion, somatostatin (SRIF)' was used to inhibit the endocrine pancreas and glucagon was replaced to basal levels via the intraportal route. The effects of twice basal insulin, i.e., hyperinsulinemia, were also examined in a similar fashion. SRIF was used to inhibit the endocrine pancreas; glucagon was replaced to basal levels, while insulin was replaced to twice basal levels via the intraportal route.
METHODS
Experiments were carried out on 17 overnight fasted mongrel dogs (20) (21) (22) (23) (24) (25) (26) kg) of either sex, which had been fed a regular dog chow diet (Wayne Dog Food, Allied Mill, Inc., Chicago, IL) for 3 wk before their use. Silastic catheters were implanted under general anesthesia in the portal vein, proximal splenic vein, hepatic vein, and femoral artery, as described (12) , 17 d before the study. After the catheters were implanted they were filled with saline containing heparin (200 U/ml, Abbott Diagnostics, Diagnostic Products, North Chicago, IL) and their free ends were knotted and placed in a subcutaneous pouch so that complete closure of skin incisions was possible. 16 Tracer methods and calculations. The rates of leucine flux in and out of the plasma compartment were determined by the constant tracer infusion method. At maximal steadystate ("plateau") arterial leucine specific activity, the amount of [3H]leucine entering the pool is equivalent to the amount of leaving the pool, assuming that the pool size remains constant. Thus, under steady-state conditions, the rate of appearance (Ra) of leucine in the plasma compartment is equal to its rate of disappearance (Rd) and is equivalent to the rate of isotope infusion in disintegrations per minute per kilogram divided by the plateau arterial specific activity in disintegrations per minute per micromole per 103. This method assumes that the reentry of isotope from the protein pool is negligible during the infusion period. Clearance (Cl) of leucine from the plasma compartment is calculated by dividing Rd (micromoles per kilogram per min) by the plasma leucine concentration (micromoles per milliliter).
During nonsteady-state conditions, calculations of the rates were carried out according to the method of Wall et al. (18) as simplified by DeBodo et al. (19) . This method is based on a single compartment analysis in which is it assumed that rapid changes in the specific activity and concentration of leucine did not occur uniformly within the entire leucine pool.
Net hepatic, splanchnic and "gut" (extrahepatic splanchnic tissue) balance of leucine and other substrates were calculated as follows: Net Net splanchnic balance = (HV-A)co)( X EHPF (2) Net "gut" balance = (PV-A),,n X 0.72EHPF, (3) where A, PV, and HV represent the plasma concentration of leucine in the artery, portal, and hepatic veins, respectively; EHPF represents the estimated hepatic plasma flow; it is estimated that portal vein supplies 72% and the artery 28% of the hepatic blood flow (12) .
Statistical analyses were performed using the Student's t test, the paired t test, and, where applicable, analysis of variance. The data in the figures and tables are expressed as mean±SEM.
RESULTS
Steady-state leucine kinetics. Fig. 1 shows the plasma leucine concentration and arterial leucine specific activity in the saline-infused control group. There was no significant change in plasma leucine concentration during 7 h of saline infusion. Leucine specific activity did not reach steady-state levels until 180 min after the start of the infusion. Because of this fact all studies were performed allowing a 3-h isotopic equilibration period, a 0.5-h basal period, followed by a perturbation period as outlined in the experimental design.
To establish whether SRIF has any effect on leucine metabolism and kinetics in the conscious dog, we measured plasma leucine concentration and flux in two overnight fasted dogs for 6 h. When SRIF was infused with intraportal replacement of basal insulin (225 sU/ kg per min) and glucagon (0.65 ng/kg per min), plasma leucine (113±3 umol/ml) and its specific activity (254±21 dpm/ymol per 103) showed no significant change from saline controls (plasma leucine = 118±6 ,mol/liter and specific activity = 261±19 dpm/tmol per 103). Table I summarizes the mean values of plasma leucine and KIC obtained during the basal period from the three study groups. There is a stepwise dilution of the arterial specific activity across the splanchnic bed. The portal and the hepatic vein specific activities were 22 and 36%, respectively, lower than that of the artery. The dilution of the specific activity across the gut is mainly due to the exchange of labeled leucine for unlabeled molecules. This is evident by the fact that the ratio of portal venous specific activity to that of the Plasma leucine concentrations in the three vessels were four-to sevenfold higher than those of KIC. The concentrations were such that there was a consistent net hepatic uptake of KIC (0.20±0.08 tsmol/kg per min) and an equivalent net hepatic output of leucine (0.24±0.03 ,umol/kg per min); the extrahepatic splanchnic tissues (the gut) extracted both KIC and leucine (Table II) . Although these values were very small, they were all statistically significant (P < 0.05). Arteriovenous differences across the hindlimb were -10±1 and -12±2 ,umol/liter for both leucine and KIC, respectively. Despite Effects of insulin on leucine kinetics. Fig. 2 shows the plasma insulin and glucagon concentrations for the three experimental groups. The intraportal replacement of glucagon resulted in comparable glucagon levels to those obtained in the saline-infused control group. When insulin was not infused, there was an 80% drop in plasma insulin from basal values of 12±1 to 2±1 MU/ml (P < 0.001) during the experimental period; the radioimmunoassay used for insulin measurement does not distinguish these latter values from zero. Infusion of intraportal insulin (600 ,U/kg per min) resulted in just over a twofold (28±2 gU/ml, P < 0.001) increase in the peripheral insulin levels.
The effect of selective changes in basal insulin on leucine metabolism can be seen in Fig. 3 (Table III) dropped significantly when insulin was withdrawn (from 25±3 ml/kg per min during the basal period to 15±0.3 ml/ kg per min by the end of 4 h, P < 0.001), while with hyperinsulinermia, there was a 65% rise in clearance (from 26±6 to 42±2 ml/kg per min by 4 h, P < 0.001).
The changes in Rd were such that Ra minus Rd was always positive with insulin deficiency and always negative with hyperinsulinemia (Fig. 4) . These changes were not significant at any particular interval, however, the cumulative changes over the entire experimental period (i.e., 4 
For each dog, the four values obtained during the basal period and the five values during the last 2 h of the experimental period were averaged. The values during the basal period did not differ among the three study groups and the values were pooled. The numbers in parentheses denote the number of dogs studied. (-) denotes release and (+) denotes uptake. All values are expressed as mean±SEM. I P < 0.05. I P < 0.05.
A-DV differences, arterio-deep femoral venous differences of leucine. had no effect on the net balance of KIC and leucine across the liver, gut, or hindlimb as shown in Table  II Concomitantly, arterio-deep femoral venous differences of leucine and KIC were -2±1 and 0±2 ,umol/ liter, respectively, indicating a marked reduction in the net release of the amino and ketoacids across the hindlimb.
The effect of saline and hormone infusion on plasma glucose were consistent with those previously reported from this laboratory (22) . During the saline control, and during the infusion of SRIF plus intraportal replacement of basal insulin and glucagon, plasma glucose levels remained stable. With twice basal hyperinsulinemia, euglycemia was maintained by an infusion of exogenous glucose. Selective insulin deficiency resulted in plasma glucose levels of 150-170 mg%, which over a period of 4 h progressively dropped to 120±4 mg% (or 23±2 mg% above basal values).
DISCUSSION
This study addresses the effects of physiologic changes in insulin concentrations on leucine metabolism in the intact animal, with special reference to the role of basal insulin in maintaining normal whole body protein homeostasis. Furthermore, the combination of the arteriovenous difference and isotopic techniques used in the present study provided valuable information regarding leucine flux that could not be obtained by either technique alone. The flux of an amino acid, defined as the rate of entry or exit from a pool can be estimated by the continuous infusion of the isotopically labeled amino acid. At steady state, the rate of appearance (Ra), or its equivalent the rate of irreversible disposal (Rd) can be calculated using the plateau-specific activity of the labeled moiety in the infused pool regardless of the volume of the pool or the configuration of the system. Ra determined in this fashion measures the rate of input of unlabeled substrate into the infused pool and does not necessarily represent the total rate of production (20) . In the current study, we have measured the influx of unlabeled leucine into the plasma pool from all sources. The leucine turnover rates measured during the basal period in all three groups of dogs were in agreement with those previously reported by us (11) and by others (21) .
Additionally, the application of the arteriovenous difference technique across the splanchnic bed and the hindlimb allows us to calculate the contribution of these tissues to total leucine turnover. During the steady-state control period,~-30% of the infused tracer was extracted across the splanchnic bed; half by the liver and the other half by the gut. This is slightly lower than alanine flux, of which >50% is accounted for by the splanchnic bed and particularly by the gut (22) . During the transit of blood from the artery to the deep femoral vein, there was a net release of leucine; this was accompanied by a net extraction of leucine radioactivity showing a process of exchange occurring across the hindlimb. If we assume that plasma flow was 0.101 liter/min (21), then from the change in the specific activities of the artery (122±25 dpm/,umol per 103) and the deep veins (95±20 dpm/jimol per 103), at least 36% of the dilution occurring across the hindlimb must have resulted from the net addition of nonradioactive leucine to plasma.
The small, but consistent net release of leucine from the splanchnic bed and the hindlimb, raises an interesting question concerning the site of net consumption FIGURE 3 The arterial plasma leucine concentration and the percent change from basal of leucine specific activity in 16-18-h fasted conscious dogs maintained on infusions of SRIF (0.8 ag/kg per min) and concurrent intraportal infusions of glucagon alone (0.65 ng/kg per minno insulin, broken line) or in combination with insulin (600 RU/kg per min-elevated insulin, solid line). The changes in the concentration of plasma leucine from control levels were significant (P < 0.05) from 90 min on, when using paired or unpaired t tests. The changes in leucine specific activity were significant (P < 0.05) only in the elevated insulin group from 60 min on (paired or unpaired t tests), when compared to both saline control or no insulin groups. of leucine. Since after an overnight fast, both muscle and splanchnic beds contribute leucine to the plasma compartment, then other sites must utilize leucine during that period. Recent data from this laboratory, obtained from a similarly fasted group of dogs, have demonstrated the capacity of the kidneys to utilize leucine at a basal rate of 0.25±0.03 ,umol/kg per min (15) . Furthermore, in vitro evidence exists for the metabolism of these amino acids by the heart (23), adipose (24) , and nervous tissues (25 (28) (29) (30) , suggest that at basal levels, insulin has a function to maintain protein synthesis slightly less than that of protein breakdown.
During acute insulin withdrawal, the isotopic data indicated that the rise in plasma leucine was not due to an increase in leucine rate of appearance in the plasma compartment but to a relative decrease in its rate of disappearance out of plasma (Fig. 4) . However, we cannot rule out the possibility that a minimum increase in Ra did occur, which in the present study would have been masked by a slight increase in recycling of 3H-label from the protein compartment. Nevertheless, most of the observed change was mainly due to the 40% decrement in leucine clearance (Table  III) . Since the observed changes in plasma leucine concentrations over the 4-h experimental period would only require the net addition of 0.06 mmol/kg per min of leucine, the arteriovenous technique might not be sensitive enough to pick these changes.
It is apparent that the initial event in twice basal hyperinsulinemia is a rapid fall in Ra. Rd also dropped in conjunction with Ra, however, the difference between the rates of entry and outflow of leucine into and out of the circulation (denoted by Ra minus Rd in Fig. 4) had decreased significantly by the end of the 4-h infusion. Under these conditions, it could be calculated that the change of Ra accounted for -50% of the change in the net balance, while Rd accounted for the rest. In this regard the net output of cold leucine by the liver and of both KIC and leucine by the hindlimb became negligible; this indicates that either the uptake of leucine by these tissues had increased and/ or its release had decreased. Thus, when the findings obtained by the arteriovenous difference technique are combined with those obtained by the tracer method, they would suggest that with hyperinsulinemia, both the liver and the hindlimb tissues (most likely skeletal muscle) participate in the observed decrement in leu- Table III . Changes from control levels were significant (P < 0.05) in the insulin deficiency and elevated insulin groups, from 60 min on when using paired or unpaired t tests.
cine rate of appearance and in the increase in its rate tion.2 Since Rd reflects changes occurring in protein of clearance from the plasma compartment.
synthesis and/or in the rate of leucine oxidation, it Though the rates of oxidation of leucine were not could be speculated that the initial event in selective measured in the present study, it would be reasonable insulin deficiency is not an increase in protein breakto assume that, if anything, leucine oxidation had in-down, while a slight physiologic rise in insulin may creased with acute insulin withdrawal, in accordance exert a dual effect on total body protein turnover, with studies on isolated skeletal muscle preparations namely, an enhancement of protein synthesis and an (8, 26) and declined in response to twice physiologic inhibition of protein breakdown. levels of insulin. Recent studies in man have shown that a comparable twofold rise in peripheral insulin levels have resulted in a 60% drop in leucine oxida-
